T-cell receptor therapy 2 articles

TCR-engineered T cells defines T-cell receptor therapy as a TCR-engineered T-cell therapy modality. The concept combines this feature with tumor antigen-specific TCR and HLA-restricted antigen recognition, then extends through peptide-MHC targeting, adoptive T-cell therapy and ex vivo T-cell engineering to support or explain tumor-associated antigen targeting. The tag remains modality-level: named therapies belong under their own product entities even when they rely on TCR-engineered T cells or closely related cell biology.